A new oral treatment for psoriatic arthritis, Celgene's Otezla, has been approved in the US. Otezla (apremilast) is Celgene's attempt to break into the immunology field currently dominated by the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback